Louisiana House passes bill to classify abortion drugs as controlled substances
The Louisiana state House recently approved an amended bill that could have profound implications for reproductive rights and healthcare in the state. This bill, which passed with a vote of 64-29, seeks to classify the abortion-inducing drugs misoprostol and mifepristone as Schedule IV controlled dangerous substances,